BIOMAT Database Logo BIOMAT Database Logo

Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers. 1998

E C Borden

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068556 Interferon beta-1a An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS. Avonex,Avonex Pen,Interferon beta 1a,Rebif,beta 1a, Interferon,beta-1a, Interferon
D016899 Interferon-beta One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity. Interferon, Fibroblast,beta-Interferon,Fiblaferon,Interferon, beta,Interferon, beta-1,Interferon-beta1,beta-1 Interferon,Fibroblast Interferon,Interferon beta,Interferon beta1,Interferon, beta 1,beta 1 Interferon,beta Interferon

Related Publications

E C Borden
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta 1a (IFN beta-1a) products administered intramuscularly in healthy male and female volunteers.
January 1998, Pharmaceutical research,
E C Borden
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers.
April 1997, Pharmaceutical research,
E C Borden
Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.
October 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
E C Borden
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
October 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
E C Borden
Pharmacokinetics and pharmacodynamics of ritodrine hydrochloride administered orally and intramuscularly to female healthy volunteers.
January 2010, Arzneimittel-Forschung,
E C Borden
Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers.
January 2002, Reproductive biomedicine online,
E C Borden
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
May 1999, European journal of neurology,
E C Borden
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
March 1998, European journal of neurology,
E C Borden
Pharmacokinetics of isoxsuprine hydrochloride administered orally and intramuscularly to female healthy volunteers.
January 2009, Arzneimittel-Forschung,
E C Borden
Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers.
October 1993, Human reproduction (Oxford, England),
Copied contents to your clipboard!